−800KRW
−5.03 BKRW
1.32 BKRW
7.24 M
About INNOTHERAPY
Sector
CEO
Moon-Soo Lee
Headquarters
Seoul
Website
Employees (FY)
30
Founded
2010
ISIN
KR7246960009
FIGI
BBG00MTS6378
InnoTherapy, Inc. engages in the manufacture and sale of hemostatic medical agents. The company operates through the Absorbable Hemostat and Surgical Sealant. Its products include homeostatic agents, sealants and adhesives. The company was founded by Moon-Soo Lee and Hae-Shin Lee on April 19, 2010 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 246960 is 8200.00 KRW — it has decreased by 1.32% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange INNOTHERAPY stocks are traded under the ticker 246960.
Yes, you can track INNOTHERAPY financials in yearly and quarterly reports right on TradingView.
Like other stocks, 246960 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOTHERAPY stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 30.00 employees. See our rating of the largest employees — is INNOTHERAPY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOTHERAPY EBITDA is −3.35 B KRW, and current EBITDA margin is −253.27%. See more stats in INNOTHERAPY financial statements.